# EDGAR Filing Document

**Accession Number:** 0001131343
**File Stem:** 0001213900-25-087427
**Filing Date:** 2025-9
**Character Count:** 9689
**Document Hash:** dc34633d79e8b9140a74d30f767b2ee5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-087427.hdr.sgml**: 20250915

**ACCESSION NUMBER**: 0001213900-25-087427

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20250915

**FILED AS OF DATE**: 20250915

**DATE AS OF CHANGE**: 20250915

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ALTERITY THERAPEUTICS LTD
- **CENTRAL INDEX KEY:** 0001131343
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** C3
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-49843
- **FILM NUMBER:** 251313221

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** LEVEL 3, 460 BOURKE STREET
- **CITY:** MELBOURNE
- **PROVINCE COUNTRY:** C3
- **BUSINESS PHONE:** 61 3 9349 4906

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** LEVEL 3, 460 BOURKE STREET
- **CITY:** MELBOURNE
- **PROVINCE COUNTRY:** C3

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PRANA BIOTECHNOLOGY LTD
- **DATE OF NAME CHANGE:** 20010105

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-163**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of September 2025**

**Alterity Therapeutics Limited**

(Name of Registrant)

**Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia**

(Address of Principal Executive Office)

**Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.**

Form 20-F ☒ Form 40-F ☐

**This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. [333-251073](http://www.sec.gov/Archives/edgar/data/1131343/000121390020040485/ea130838-s8_alteritytherape.htm), [333-248980](http://www.sec.gov/Archives/edgar/data/1131343/000121390020027969/ea127207-s8_alteritytherap.htm) and [333-228671](http://www.sec.gov/Archives/edgar/data/1131343/000114420418063081/tv508429_s-8.htm)) and our Registration Statements on Form F-3 (Files No. [333-274816](http://www.sec.gov/Archives/edgar/data/1131343/000101376223000033/ea185947-f3_alteritytherape.htm), [333-251647](http://www.sec.gov/Archives/edgar/data/1131343/000121390020044324/ea132148-f3_alteritytherape.htm), [333-231417](http://www.sec.gov/Archives/edgar/data/1131343/000114420419025615/tv521271_f3.htm) and [333-250076](http://www.sec.gov/Archives/edgar/data/1131343/000121390020036934/ea129831-f3_alteritytherap.htm))**

**ALTERITY THERAPEUTICS LIMITED**

**(a development stage enterprise)**

The following exhibits are submitted:

99.1 [Application for Quotation of Securities](ea025733101ex99-1_alterity.htm)

**<u>SIGNATURE</u>**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| **Alterity Therapeutics Limited** | **Alterity Therapeutics Limited** |
| By: | /s/ Geoffrey P. Kempler |
|  | Geoffrey P. Kempler |
|  | Chairman |

---

Date: September 15, 2025

## Exhibit 99.1

**Exhibit 99.1**

---

| | |
|:---|:---|
| ![](ex99-1_001.jpg) | Appendix 2A - Application for quotation of securities |

---

Announcement Summary

**Entity name**

ALTERITY THERAPEUTICS LIMITED

**Announcement Type**

New announcement

**Date of this announcement**

Monday September 15, 2025

**The +securities to be quoted are:**

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

**Total number of +securities to be quoted**

---

| | | | |
|:---|:---|:---|:---|
| **ASX +security code** | **Security description** | **Number of +securities to be quoted** | **Issue date** |
| ATH | ORDINARY FULLY PAID | 1666666663 | 15/09/2025 |

---

Refer to next page for full details of the announcement

Appendix 2A - Application for quotation of securities 1 / 6

---

| | |
|:---|:---|
| ![](ex99-1_001.jpg) | Appendix 2A - Application for quotation of securities |

---

Part 1 - Entity and announcement details

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1.1 Name of entity**

ALTERITY THERAPEUTICS LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

---

| | |
|:---|:---|
| **1.2 Registered number type** | **Registration number** |
| ABN | 37080699065 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1.3 ASX issuer code**

ATH

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1.4 The announcement is**

New announcement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1.5 Date of this announcement**

15/9/2025

Appendix 2A - Application for quotation of securities 2 / 6

---

| | |
|:---|:---|
| ![](ex99-1_001.jpg) | Appendix 2A - Application for quotation of securities |

---

Part 2 - Type of Issue

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1 The +securities to be quoted are:

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

**Previous Appendix 3B details:**

---

| | | |
|:---|:---|:---|
| **Announcement Date and Time** | **Announcement Title** | **Selected Appendix 3B to submit quotation request** |
| 08-Sep-2025 09:47 | New - Proposed issue of securities - ATH | A placement or other type of issue |

---

**2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?**

No

Appendix 2A - Application for quotation of securities 3 / 6

---

| | |
|:---|:---|
| ![](ex99-1_001.jpg) | Appendix 2A - Application for quotation of securities |

---

Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B

Placement Details

**ASX +security code and description**<br> ATH : ORDINARY FULLY PAID <br>

**Issue date** <br> 15/9/2025

**Distribution Schedule** 

**Provide a distribution schedule for the new +securities according to the categories set out in the left hand column - including the number of recipients and the total percentage of the new +securities held by the recipients in each category.** 

---

| | | |
|:---|:---|:---|
|  |  | **Total percentage of +securities held** |
| **Number of +securities held** | **Number of holders** | For example, to enter a value of 50% |
|  |  | please input as 50.00 |
| 1 - 1000 |  | % |
| 1001 - 5000 |  | % |
| 5001 - 10000 |  | % |
| 10001 - 100000 |  | % |
| 100,001 and over |  | % |

---

Appendix 2A - Application for quotation of securities 4 / 6

---

| | |
|:---|:---|
| ![](ex99-1_001.jpg) | Appendix 2A - Application for quotation of securities |

---

Issue details

**Number of +securities to be quoted**

1,666,666,663

**Are the +securities being issued for a cash consideration?**

Yes

---

| | |
|:---|:---|
| **In what currency is the cash consideration being paid?** | **What is the issue price per +security?** |
| AUD - Australian Dollar | AUD 0.01200000 |

---

**Any other information the entity wishes to provide about the +securities to be quoted**

Appendix 2A - Application for quotation of securities 5 / 6

---

| | |
|:---|:---|
| ![](ex99-1_001.jpg) | Appendix 2A - Application for quotation of securities |

---

Part 4 - Issued capital following quotation

**Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:**

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

---

| | |
|:---|:---|
| **ASX +security code and description** | **Total number of**<br> **+securities on issue** |
| ATH : ORDINARY FULLY PAID | 10875416329 |
| ATHO : OPTION EXPIRING 31-AUG-2026 | 931232089 |
| ATHOA : OPTION EXPIRING 26-FEB-2027 | 1222300911 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

---

| | |
|:---|:---|
| **ASX +security code and description** | **Total number of**<br> **+securities on issue** |
| ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 | 10000000 |
| ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 | 11500000 |
| ATHAE : OPTION EXPIRING 08-AUG-2030 EX $0.013 | 11500000 |
| ATHAF : OPTION EXPIRING 08-AUG-2030 EX USD 0.0086 | 312400200 |
| ATHAD : OPTION EXPIRING 01-JUL-2030 EX $0.01 | 15000000 |
| ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 | 35000000 |
| ATHAAK : OPTION EXPIRING 30-DEC-2027 EX $0.01 | 170000000 |
| ATHAAH : OPTION EXPIRING 19-DEC-2026 EX $0.0105 | 8000000 |
| ATHAB : OPTION EXPIRING 13-MAR-2029 EX US$0.0031 | 62500000 |
| ATHAA : OPTION EXPIRING 13-MAR-2029 EX $0.004 | 20166667 |
| ATHAC : OPTION EXPIRING 21-MAR-2029 EX US$0.003 | 40000200 |
| ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 | 91392720 |

---

Appendix 2A - Application for quotation of securities 6 / 6